Table of Content

1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 46
1.3 STUDY SCOPE 47
1.3.1 MARKETS COVERED 47
1.3.2 REGIONAL SCOPE 48
1.3.3 INCLUSIONS & EXCLUSIONS 48
1.3.4 YEARS CONSIDERED 49
1.3.5 CURRENCY CONSIDERED 49
1.4 STAKEHOLDERS 49
1.5 SUMMARY OF CHANGES 50
2 RESEARCH METHODOLOGY 51
2.1 RESEARCH DATA 51
2.1.1 SECONDARY RESEARCH 52
2.1.2 PRIMARY RESEARCH 52
2.1.2.1 Key industry insights 54
2.2 MARKET SIZE ESTIMATION 54
2.2.1 GLOBAL MARKET ESTIMATION 55
2.2.1.1 Approach 1: Company revenue analysis (bottom-up approach) 55
2.2.1.2 Approach 2: MNM repository analysis 56
2.2.1.3 Approach 3: Primary interviews 56
2.2.2 SEGMENTAL MARKET ESTIMATION 57
2.2.2.1 Top-down approach 57
2.3 MARKET GROWTH RATE PROJECTIONS 58
2.4 DATA TRIANGULATION 60
2.5 RESEARCH ASSUMPTIONS 61
2.6 RESEARCH LIMITATIONS 62
2.7 RISK ANALYSIS 62
3 EXECUTIVE SUMMARY 63
4 PREMIUM INSIGHTS 66
4.1 CELL COUNTING MARKET OVERVIEW 66
4.2 NORTH AMERICA: CELL COUNTING MARKET, BY APPLICATION AND COUNTRY, 2023 67
4.3 CELL COUNTING MARKET, BY END USER, 2024 VS. 2029 67
4.4 CELL COUNTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68
?
5 MARKET OVERVIEW 69
5.1 INTRODUCTION 69
5.2 MARKET DYNAMICS 69
5.2.1 DRIVERS 70
5.2.1.1 Technological advancements 70
5.2.1.2 Expanding applications in research and diagnostics 71
5.2.1.3 Rise in personalized medicine 71
5.2.2 RESTRAINTS 72
5.2.2.1 High cost of advanced systems 72
5.2.3 OPPORTUNITIES 72
5.2.3.1 Advancements in stem cell research 72
5.2.3.2 Rising demand for point-of-care diagnostics 72
5.2.4 CHALLENGES 73
5.2.4.1 Regulatory and compliance challenges 73
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
5.4 PRICING ANALYSIS 74
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 74
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 76
5.5 SUPPLY CHAIN ANALYSIS 78
5.6 VALUE CHAIN ANALYSIS 79
5.7 ECOSYSTEM ANALYSIS 82
5.7.1 CELL COUNTING MARKET: RAW MATERIAL PROVIDERS 82
5.7.2 CELL COUNTING MARKET: PRODUCT MANUFACTURERS/PROVIDERS 83
5.7.3 CELL COUNTING MARKET: END USERS 83
5.7.4 CELL COUNTING MARKET: REGULATORY BODIES 84
5.8 INVESTMENT & FUNDING SCENARIO 84
5.9 TECHNOLOGY ANALYSIS 85
5.9.1 KEY TECHNOLOGIES 85
5.9.1.1 Automated cell counting 85
5.9.1.2 Flow cytometry 85
5.9.1.3 Image-based cell counting 86
5.9.2 COMPLEMENTARY TECHNOLOGIES 86
5.9.2.1 Cell culture 86
5.9.2.2 Centrifugation 86
5.9.2.3 Cell viability testing 86
5.9.3 ADJACENT TECHNOLOGIES 87
5.9.3.1 Genomic sequencing 87
5.9.3.2 Polymerase chain reaction (PCR) 87
5.9.3.3 Tissue engineering 87
?
5.10 PATENT ANALYSIS 88
5.11 TRADE ANALYSIS 90
5.11.1 TRADE DATA FOR FLOW CYTOMETERS 90
5.11.1.1 Import data for flow cytometers 90
5.11.1.2 Export data for flow cytometers 92
5.12 KEY CONFERENCES & EVENTS, 2025–2026 93
5.13 REGULATORY LANDSCAPE 94
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.13.2 REGULATORY FRAMEWORK 96
5.13.2.1 North America 96
5.13.2.2 Europe 96
5.13.2.3 Asia Pacific 97
5.14 PORTER’S FIVE FORCES ANALYSIS 97
5.14.1 THREAT OF NEW ENTRANTS 98
5.14.2 BARGAINING POWER OF SUPPLIERS 98
5.14.3 BARGAINING POWER OF BUYERS 99
5.14.4 THREAT OF SUBSTITUTES 99
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 99
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 99
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
5.15.2 BUYING CRITERIA 101
5.16 IMPACT OF AI/GENERATIVE AI ON CELL COUNTING MARKET 102
5.16.1 INTRODUCTION 102
5.16.2 IMPACT OF AI ON CELL COUNTING ECOSYSTEM 103
5.16.3 FUTURE OF GENERATIVE AI IN CELL COUNTING ECOSYSTEM 104
6 CELL COUNTING MARKET, BY PRODUCT 105
6.1 INTRODUCTION 106
6.2 CONSUMABLES 106
6.2.1 MEDIA, SERA, AND REAGENTS 110
6.2.1.1 Rising demand for buffers & solvents in research & diagnostics to drive market 110
6.2.2 ASSAY KITS 113
6.2.2.1 Cell viability assays 116
6.2.2.1.1 Critical evaluation of cytotoxicity to drive segment growth 116
6.2.2.2 Cell staining assays 119
6.2.2.2.1 Advancements in imaging systems and flow cytometry to boost demand 119
6.2.2.3 Cytotoxicity assays 122
6.2.2.3.1 Provision of insights into cell viability & membrane integrity to fuel uptake 122
?
6.2.2.4 Calorimetric assays 125
6.2.2.4.1 Assessment of biochemical reactions to drive segment growth 125
6.2.2.5 Other assays 128
6.2.3 MICROPLATES 131
6.2.3.1 Rising utilization in high-throughput research to drive market 131
6.2.4 ACCESSORIES 134
6.2.4.1 Increasing demand for essential components like sensors & electrical accessories to support market growth 134
6.2.5 OTHER CONSUMABLES 137
6.3 INSTRUMENTS 139
6.3.1 SPECTROPHOTOMETERS 142
6.3.1.1 Single-mode readers 145
6.3.1.1.1 Wide utilization across research & industrial labs to boost demand 145
6.3.1.2 Multi-mode readers 148
6.3.1.2.1 Advanced data visualization software to support segment growth 148
6.3.2 FLOW CYTOMETERS 151
6.3.2.1 Wide uptake in clinical & research applications to propel market 151
6.3.3 HEMATOLOGY ANALYZERS 153
6.3.3.1 Fully automated Analyzers 156
6.3.3.1.1 High yield with minimal manual intervention to drive segment growth 156
6.3.3.2 Semi-automated Analyzers 159
6.3.3.2.1 Cost-efficiency and compact size to fuel uptake 159
6.3.4 CELL COUNTERS 162
6.3.4.1 Cell Counters, by mode 164
6.3.4.1.1 Automated cell counters 165
6.3.4.1.1.1 Reliable and rapid results to boost demand 165
6.3.4.1.2 Manual cell counters 168
6.3.4.1.2.1 High accuracy to support segment growth 168
6.3.4.2 Cell Counters, by technique 170
6.3.4.2.1 Fluorescence-based cell counters 171
6.3.4.2.1.1 Precise quantification of cell populations to drive segment growth 171
6.3.4.2.2 Image-based cell counters 174
6.3.4.2.2.1 Integration of image-based systems into laboratory workflows to fuel uptake 174
6.3.4.2.3 Brightfield cell counters 177
6.3.4.2.3.1 Increasing demand for efficient and cost-effective cell counting solutions to boost demand 177
6.3.4.2.4 Other cell counters 179
?
6.3.5 MICROSCOPES 182
6.3.5.1 Advancements in cell-based therapies to drive market 182
6.3.6 OTHER INSTRUMENTS 185
7 CELL COUNTING MARKET, BY APPLICATION 188
7.1 INTRODUCTION 189
7.2 RESEARCH APPLICATIONS 189
7.2.1 CANCER RESEARCH 193
7.2.1.1 Rising prevalence of cancer and growing focus on early detection to drive market 193
7.2.2 IMMUNOLOGY RESEARCH 197
7.2.2.1 Rising prevalence of autoimmune diseases to fuel market 197
7.2.3 NEUROLOGY RESEARCH 199
7.2.3.1 Rising incidence of neurological disorders to propel market 199
7.2.4 STEM CELL RESEARCH 202
7.2.4.1 Favorable R&D investments to boost demand 202
7.2.5 OTHER RESEARCH APPLICATIONS 205
7.3 MEDICAL APPLICATIONS 208
7.3.1 HEMATOLOGY & COMPLETE BLOOD COUNT 211
7.3.1.1 Uptake of hematology analyzers in diagnosis of anemia & leukemia to drive market 211
7.3.2 NON-INVASIVE PRENATAL DIAGNOSTICS 214
7.3.2.1 Provision of critical insights into fetal health to support market growth 214
7.3.3 IN VITRO FERTILIZATION 217
7.3.3.1 Increasing prevalence of infertility and advancements in assisted reproductive technologies to drive market 217
7.3.4 CIRCULATING TUMOR CELL DETECTION 219
7.3.4.1 Growing focus on precision oncology and liquid biopsies to fuel market 219
7.3.5 OTHER MEDICAL APPLICATIONS 222
7.4 OTHER INDUSTRIAL APPLICATIONS 225
8 CELL COUNTING MARKET, BY END USER 228
8.1 INTRODUCTION 229
8.2 ACADEMIC & RESEARCH INSTITUTES 229
8.2.1 ADVANCEMENTS IN STEM CELL RESEARCH AND GROWING FOCUS ON LIFE SCIENCES TO PROPEL MARKET 229
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES 233
8.3.1 RISING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO DRIVE MARKET 233
8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 236
8.4.1 EXPANDING PIPELINE OF BIOLOGICS TO FUEL MARKET 236
8.5 OTHER END USERS 239
9 CELL COUNTING MARKET, BY REGION 242
9.1 INTRODUCTION 243
9.2 NORTH AMERICA 243
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 244
9.2.2 US 250
9.2.2.1 US to dominate North American cell counting market during study period 250
9.2.3 CANADA 255
9.2.3.1 Rising demand for advanced research tools in biopharmaceutical and academic research to drive market 255
9.3 EUROPE 260
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 260
9.3.2 GERMANY 266
9.3.2.1 Robust biopharma manufacturing and substantial federal R&D investments to aid market growth 266
9.3.3 UK 271
9.3.3.1 Favorable government funding for pharmaceutical & biotechnology research to support market growth 271
9.3.4 FRANCE 276
9.3.4.1 Favorable government initiatives and increased investments by foreign pharmaceutical companies to aid market growth 276
9.3.5 ITALY 281
9.3.5.1 Advanced life science research biomanufacturing facilities to augment market growth 281
9.3.6 SPAIN 286
9.3.6.1 Emphasis on biopharmaceutical innovation and cancer research to stimulate market growth 286
9.3.7 REST OF EUROPE 291
9.4 ASIA PACIFIC 296
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 296
9.4.2 CHINA 303
9.4.2.1 Growing prominence in clinical trials and biologics production to fuel market growth 303
9.4.3 JAPAN 308
9.4.3.1 High availability of funding and technological expertise to support market growth 308
9.4.4 INDIA 313
9.4.4.1 Favorable FDI regulations in pharmaceutical industry to boost market growth 313
9.4.5 SOUTH KOREA 318
9.4.5.1 Increasing healthcare expenditure and rising government R&D budget to fuel uptake 318
9.4.6 AUSTRALIA 323
9.4.6.1 Focus on translational research and clinical trials in cancer therapies and regenerative medicines to drive market 323
9.4.7 REST OF ASIA PACIFIC 328
9.5 LATIN AMERICA 333
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 334
9.5.2 BRAZIL 339
9.5.2.1 Robust healthcare infrastructure and high prevalence of chronic diseases to propel demand for cell-counting technologies 339
9.5.3 MEXICO 343
9.5.3.1 Burgeoning pharmaceutical industry and increased collaborations among industry leaders to propel market growth 343
9.5.4 REST OF LATIN AMERICA 348
9.6 MIDDLE EAST 353
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 353
9.6.2 GCC COUNTRIES 359
9.6.2.1 Saudi Arabia 364
9.6.2.1.1 Growing focus on public-private partnerships and rising investments in healthcare modernization to drive market 364
9.6.2.2 UAE 370
9.6.2.2.1 World-class healthcare infrastructure to drive adoption of cell counting technologies 370
9.6.2.3 Rest of GCC Countries 375
9.6.3 REST OF MIDDLE EAST 380
9.7 AFRICA 386
9.7.1 HIGH GOVERNMENT HEALTHCARE BUDGET AND INCREASED POPULARITY AS BIOTECH HUB TO SUPPORT MARKET GROWTH 386
9.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 386
10 COMPETITIVE LANDSCAPE 392
10.1 OVERVIEW 392
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 392
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL COUNTING MARKET 393
10.3 REVENUE ANALYSIS, 2019–2023 394
10.4 MARKET SHARE ANALYSIS, 2023 395
10.5 COMPANY VALUATION AND FINANCIAL METRICS 397
10.5.1 COMPANY VALUATION 397
10.5.2 FINANCIAL METRICS 398
10.6 BRAND/PRODUCT COMPARISON 399
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 400
10.7.1 STARS 400
10.7.2 EMERGING LEADERS 400
10.7.3 PERVASIVE PLAYERS 400
10.7.4 PARTICIPANTS 400
?
10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 402
10.7.5.1 Company footprint 402
10.7.5.2 Region footprint 403
10.7.5.3 Product footprint 404
10.7.5.4 Application footprint 405
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 406
10.8.1 PROGRESSIVE COMPANIES 406
10.8.2 RESPONSIVE COMPANIES 406
10.8.3 DYNAMIC COMPANIES 406
10.8.4 STARTING BLOCKS 406
10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 408
10.8.5.1 Detailed list of key startups/SMEs 408
10.8.5.2 Competitive benchmarking of startups/SMEs 409
10.9 COMPETITIVE SCENARIO 410
10.9.1 PRODUCT LAUNCHES 410
10.9.2 DEALS 411
10.9.3 EXPANSIONS 412
11 COMPANY PROFILES 413
11.1 KEY PLAYERS 413
11.1.1 DANAHER CORPORATION 413
11.1.1.1 Business overview 413
11.1.1.2 Products offered 415
11.1.1.3 Recent developments 419
11.1.1.3.1 Product launches 419
11.1.1.3.2 Deals 419
11.1.1.4 MnM view 419
11.1.1.4.1 Key strengths 419
11.1.1.4.2 Strategic choices 420
11.1.1.4.3 Weaknesses and competitive threats 420
11.1.2 THERMO FISHER SCIENTIFIC INC. 421
11.1.2.1 Business overview 421
11.1.2.2 Products offered 423
11.1.2.3 Recent developments 425
11.1.2.3.1 Deals 425
11.1.2.4 MnM view 425
11.1.2.4.1 Key strengths 425
11.1.2.4.2 Strategic choices 426
11.1.2.4.3 Weaknesses and competitive threats 426
?
11.1.3 AGILENT TECHNOLOGIES, INC. 427
11.1.3.1 Business overview 427
11.1.3.2 Products offered 429
11.1.3.3 Recent developments 433
11.1.3.3.1 Expansions 433
11.1.3.4 MnM view 434
11.1.3.4.1 Key strengths 434
11.1.3.4.2 Strategic choices 434
11.1.3.4.3 Weaknesses and competitive threats 434
11.1.4 BD 435
11.1.4.1 Business overview 435
11.1.4.2 Products offered 437
11.1.4.3 Recent developments 440
11.1.4.3.1 Product launches 440
11.1.4.4 MnM view 441
11.1.4.4.1 Key strengths 441
11.1.4.4.2 Strategic choices 441
11.1.4.4.3 Weaknesses and competitive threats 441
11.1.5 ABBOTT LABORATORIES 442
11.1.5.1 Business overview 442
11.1.5.2 Products offered 444
11.1.5.3 MnM view 444
11.1.5.3.1 Key strengths 444
11.1.5.3.2 Strategic choices 444
11.1.5.3.3 Weaknesses and competitive threats 445
11.1.6 MERCK KGAA 446
11.1.6.1 Business overview 446
11.1.6.2 Products offered 448
11.1.6.3 Recent developments 450
11.1.6.3.1 Deals 450
11.1.6.3.2 Expansions 450
11.1.7 REVVITY 451
11.1.7.1 Business overview 451
11.1.7.2 Products offered 453
11.1.7.3 Recent developments 456
11.1.7.3.1 Product launches 456
11.1.7.3.2 Deals 456
11.1.8 BIO-RAD LABORATORIES, INC. 457
11.1.8.1 Business overview 457
11.1.8.2 Products offered 459
?
11.1.9 CORNING INCORPORATED 463
11.1.9.1 Business overview 463
11.1.9.2 Products offered 465
11.1.10 TECAN TRADING AG 467
11.1.10.1 Business overview 467
11.1.10.2 Products offered 469
11.1.11 BOULE 470
11.1.11.1 Business overview 470
11.1.11.2 Products offered 472
11.1.11.3 Recent developments 473
11.1.11.3.1 Deals 473
11.1.12 HORIBA 474
11.1.12.1 Business overview 474
11.1.12.2 Products offered 476
11.1.12.3 Recent developments 477
11.1.12.3.1 Product launches 477
11.1.13 SIEMENS HEALTHINEERS AG 478
11.1.13.1 Business overview 478
11.1.13.2 Products offered 480
11.1.13.3 Recent developments 481
11.1.13.3.1 Product launches 481
11.1.14 EVIDENT 482
11.1.14.1 Business overview 482
11.1.14.2 Products offered 482
11.1.14.3 Recent developments 484
11.1.14.3.1 Product launches 484
11.1.14.3.2 Deals 484
11.1.14.3.3 Expansions 484
11.1.15 F. HOFFMANN-LA ROCHE LTD 485
11.1.15.1 Business overview 485
11.1.15.2 Products offered 487
11.1.16 SYSMEX CORPORATION 488
11.1.16.1 Business overview 488
11.1.16.2 Products offered 489
11.1.16.3 Recent developments 491
11.1.16.3.1 Product launches 491
11.1.16.3.2 Deals 492
11.2 OTHER PLAYERS 493
11.2.1 CYTEK BIOSCIENCES 493
11.2.2 TIP BIOSYSTEMS 494
11.2.3 ALIGNED GENETICS 495
11.2.4 YOKOGAWA ELECTRIC CORPORATION 496
11.2.5 COLE-PARMER INSTRUMENT COMPANY, LLC 497
11.2.6 MILTENYI BIOTEC 498
11.2.7 LONZA 499
11.2.8 BIOLINE TECHNOLOGIES 500
11.2.9 NIKON CORPORATION 501
11.2.10 AXON BIOSYTEMS, INC. 502
11.2.11 CREATIVE BIOARRAY 503
12 APPENDIX 504
12.1 DISCUSSION GUIDE 504
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS? SUBSCRIPTION PORTAL 508
12.3 CUSTOMIZATION OPTIONS 510
12.4 RELATED REPORTS 510
12.5 AUTHOR DETAILS 511



List of Figures

FIGURE 1 CELL COUNTING MARKET SEGMENTATION 47
FIGURE 2 CELL COUNTING MARKET: RESEARCH DESIGN 51
FIGURE 3 CELL COUNTING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 53
FIGURE 4 CELL COUNTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 54
FIGURE 5 CELL COUNTING MARKET ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 55
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE
SHARE ANALYSIS (2023) 56
FIGURE 7 SEGMENTAL MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 57
FIGURE 8 CELL COUNTING MARKET: CAGR PROJECTIONS 58
FIGURE 9 DATA TRIANGULATION METHODOLOGY 60
FIGURE 10 CELL COUNTING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 63
FIGURE 11 CELL COUNTING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 64
FIGURE 12 CELL COUNTING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 64
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF CELL COUNTING MARKET 65
FIGURE 14 INCREASING DEMAND FOR CELL-BASED RESEARCH TO DRIVE MARKET 66
FIGURE 15 RESEARCH APPLICATIONS DOMINATED NORTH AMERICAN MARKET IN 2023 67
FIGURE 16 ACADEMIC & RESEARCH INSTITUTES TO DOMINATE MARKET
DURING FORECAST PERIOD 67
FIGURE 17 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 68
FIGURE 18 CELL COUNTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES 69
FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
FIGURE 20 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 76
FIGURE 21 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 77
FIGURE 22 CELL COUNTING MARKET: SUPPLY CHAIN ANALYSIS 78
FIGURE 23 CELL COUNTING MARKET: VALUE CHAIN ANALYSIS 80
FIGURE 24 CELL COUNTING MARKET: ECOSYSTEM ANALYSIS 82
FIGURE 25 FUNDING ESTIMATES FOR STEM CELL RESEARCH, 2019–2025 85
FIGURE 26 CELL COUNTING MARKET: PATENT ANALYSIS, 2014?2024 88
FIGURE 27 CELL COUNTING MARKET: PORTER’S FIVE FORCES ANALYSIS 98
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 100
FIGURE 29 KEY BUYING CRITERIA FOR CELL COUNTING PRODUCTS, BY END USER 101
FIGURE 30 NORTH AMERICA: CELL COUNTING MARKET SNAPSHOT 245
FIGURE 31 US: FUNDING BY NATIONAL INSTITUTES OF HEALTH, 2014–2024 251
FIGURE 32 ASIA PACIFIC: CELL COUNTING MARKET SNAPSHOT 298
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN CELL COUNTING MARKET, 2019–2023 395
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL COUNTING MARKET, 2023 396
FIGURE 35 EV/EBITDA OF KEY VENDORS, 2025 397
FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS, 2025 398
FIGURE 37 CELL COUNTING MARKET: BRAND/PRODUCT COMPARISON (CELL COUNTERS) 399
FIGURE 38 CELL COUNTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 401
FIGURE 39 CELL COUNTING MARKET: COMPANY FOOTPRINT 402
FIGURE 40 CELL COUNTING MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 407
FIGURE 41 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 414
FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 422
FIGURE 43 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 428
FIGURE 44 BD: COMPANY SNAPSHOT (2024) 436
FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023) 443
FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023) 447
FIGURE 47 REVVITY: COMPANY SNAPSHOT (2023) 452
FIGURE 48 BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT (2023) 458
FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2023) 464
FIGURE 50 TECAN TRADING AG: COMPANY SNAPSHOT (2023) 468
FIGURE 51 BOULE: COMPANY SNAPSHOT (2023) 471
FIGURE 52 HORIBA: COMPANY SNAPSHOT (2023) 475
FIGURE 53 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 479
FIGURE 54 F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT (2023) 486
FIGURE 55 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023) 489

List of Tables

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 59
TABLE 2 CELL COUNTING MARKET: RISK ANALYSIS 62
TABLE 3 CELL COUNTING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 70
TABLE 4 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 75
TABLE 5 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022–2024 77
TABLE 6 CELL COUNTING MARKET: RAW MATERIAL PROVIDERS 82
TABLE 7 CELL COUNTING MARKET: PRODUCT MANUFACTURERS/PROVIDERS 83
TABLE 8 CELL COUNTING MARKET: END USERS 83
TABLE 9 CELL COUNTING MARKET: REGULATORY BODIES 84
TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024 89
TABLE 11 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY 2017–2021 (USD THOUSAND) 90
TABLE 12 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY 2022–2023 (USD THOUSAND) 91
TABLE 13 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY 2022–2023 (UNITS) 91
TABLE 14 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY 2017–2021 (USD THOUSAND) 92
TABLE 15 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY 2022–2023 (USD THOUSAND) 92
TABLE 16 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY 2022–2023 (UNITS) 93
TABLE 17 CELL COUNTING MARKET: KEY CONFERENCES & EVENTS, 2025–2026 93
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 22 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 23 CELL COUNTING MARKET: PORTER’S FIVE FORCES ANALYSIS 97
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 100
TABLE 25 KEY BUYING CRITERIA FOR CELL COUNTING PRODUCTS, BY END USER 101
TABLE 26 CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 106
TABLE 27 CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 107
TABLE 28 CELL COUNTING CONSUMABLES MARKET, BY REGION 2022–2029 (USD MILLION) 107
TABLE 29 NORTH AMERICA: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 107
TABLE 30 EUROPE: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 108
TABLE 31 ASIA PACIFIC: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 108
TABLE 32 LATIN AMERICA: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 109
TABLE 33 MIDDLE EAST: CELL COUNTING CONSUMABLES MARKET, BY REGION 2022–2029 (USD MILLION) 109
TABLE 34 GCC COUNTRIES: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 109
TABLE 35 CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY REGION 2022–2029 (USD MILLION) 110
TABLE 36 NORTH AMERICA: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 37 EUROPE: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 38 ASIA PACIFIC: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 39 LATIN AMERICA: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 40 MIDDLE EAST: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET BY REGION, 2022–2029 (USD MILLION) 112
TABLE 41 GCC COUNTRIES: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 42 CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 113
TABLE 43 CELL COUNTING ASSAY KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 114
TABLE 44 NORTH AMERICA: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 114
TABLE 45 EUROPE: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 114
TABLE 46 ASIA PACIFIC: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 115
TABLE 47 LATIN AMERICA: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 115
TABLE 48 MIDDLE EAST: CELL COUNTING ASSAY KITS MARKET, BY REGION 2022–2029 (USD MILLION) 115
TABLE 49 GCC COUNTRIES: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 116
TABLE 50 CELL VIABILITY ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 51 NORTH AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 117
TABLE 52 EUROPE: CELL VIABILITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 117
TABLE 53 ASIA PACIFIC: CELL VIABILITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 118
TABLE 54 LATIN AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 118
TABLE 55 MIDDLE EAST: CELL VIABILITY ASSAYS MARKET, BY REGION 2022–2029 (USD MILLION) 118
TABLE 56 GCC COUNTRIES: CELL VIABILITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 119
TABLE 57 CELL STAINING ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 58 NORTH AMERICA: CELL STAINING ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 120
TABLE 59 EUROPE: CELL STAINING ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 120
TABLE 60 ASIA PACIFIC: CELL STAINING ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 121
TABLE 61 LATIN AMERICA: CELL STAINING ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 121
TABLE 62 MIDDLE EAST: CELL STAINING ASSAYS MARKET, BY REGION 2022–2029 (USD MILLION) 121
TABLE 63 GCC COUNTRIES: CELL STAINING ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 122
TABLE 64 CYTOTOXICITY ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 123
TABLE 65 NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 123
TABLE 66 EUROPE: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 123
TABLE 67 ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 124
TABLE 68 LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 124
TABLE 69 MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION 2022–2029 (USD MILLION) 124
TABLE 70 GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 125
TABLE 71 CALORIMETRIC ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 126
TABLE 72 NORTH AMERICA: CALORIMETRIC ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 126
TABLE 73 EUROPE: CALORIMETRIC ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 126
TABLE 74 ASIA PACIFIC: CALORIMETRIC ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 127
TABLE 75 LATIN AMERICA: CALORIMETRIC ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 127
TABLE 76 MIDDLE EAST: CALORIMETRIC ASSAYS MARKET, BY REGION 2022–2029 (USD MILLION) 127
TABLE 77 GCC COUNTRIES: CALORIMETRIC ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 128
TABLE 78 OTHER ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 79 NORTH AMERICA: OTHER ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 129
TABLE 80 EUROPE: OTHER ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 81 ASIA PACIFIC: OTHER ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 82 LATIN AMERICA: OTHER ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 130
TABLE 83 MIDDLE EAST: OTHER ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 130
TABLE 84 GCC COUNTRIES: OTHER ASSAYS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 131
TABLE 85 CELL COUNTING MICROPLATES MARKET, BY REGION, 2022–2029 (USD MILLION) 132
TABLE 86 NORTH AMERICA: CELL COUNTING MICROPLATES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 132
TABLE 87 EUROPE: CELL COUNTING MICROPLATES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 132
TABLE 88 ASIA PACIFIC: CELL COUNTING MICROPLATES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 133
TABLE 89 LATIN AMERICA: CELL COUNTING MICROPLATES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 133
TABLE 90 MIDDLE EAST: CELL COUNTING MICROPLATES MARKET, BY REGION 2022–2029 (USD MILLION) 133
TABLE 91 GCC COUNTRIES: CELL COUNTING MICROPLATES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 134
TABLE 92 CELL COUNTING ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 134
TABLE 93 NORTH AMERICA: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 135
TABLE 94 EUROPE: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 135
TABLE 95 ASIA PACIFIC: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 135
TABLE 96 LATIN AMERICA: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 136
TABLE 97 MIDDLE EAST: CELL COUNTING ACCESSORIES MARKET, BY REGION 2022–2029 (USD MILLION) 136
TABLE 98 GCC COUNTRIES: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 136
TABLE 99 OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 137
TABLE 100 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 137
TABLE 101 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 138
TABLE 102 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 138
TABLE 103 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 138
TABLE 104 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION 2022–2029 (USD MILLION) 139
TABLE 105 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 139
TABLE 106 CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 140
TABLE 107 CELL COUNTING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 140
TABLE 108 NORTH AMERICA: CELL COUNTING INSTRUMENTS, BY COUNTRY 2022–2029 (USD MILLION) 140
TABLE 109 EUROPE: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 141
TABLE 110 ASIA PACIFIC: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 141
TABLE 111 LATIN AMERICA: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 141
TABLE 112 MIDDLE EAST: CELL COUNTING INSTRUMENTS MARKET, BY REGION 2022–2029 (USD MILLION) 142
TABLE 113 GCC COUNTRIES: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 142
TABLE 114 CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE 2022–2029 (USD MILLION) 143
TABLE 115 CELL COUNTING SPECTROPHOTOMETERS MARKET, BY REGION 2022–2029 (USD MILLION) 143
TABLE 116 NORTH AMERICA: CELL COUNTING SPECTROPHOTOMETERS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 117 EUROPE: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 144
TABLE 118 ASIA PACIFIC: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 119 LATIN AMERICA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 120 MIDDLE EAST: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 145
TABLE 121 GCC COUNTRIES: CELL COUNTING SPECTROPHOTOMETERS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 122 SINGLE-MODE READERS MARKET, BY REGION, 2022–2029 (USD MILLION) 146
TABLE 123 NORTH AMERICA: SINGLE-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 146
TABLE 124 EUROPE: SINGLE-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 146
TABLE 125 ASIA PACIFIC: SINGLE-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 147
TABLE 126 LATIN AMERICA: SINGLE-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 147
TABLE 127 MIDDLE EAST: SINGLE-MODE READERS MARKET, BY REGION 2022–2029 (USD MILLION) 147
TABLE 128 GCC COUNTRIES: SINGLE-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 148
TABLE 129 MULTI-MODE READERS MARKET, BY REGION, 2022–2029 (USD MILLION) 148
TABLE 130 NORTH AMERICA: MULTI-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 149
TABLE 131 EUROPE: MULTI-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 149
TABLE 132 ASIA PACIFIC: MULTI-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 149
TABLE 133 LATIN AMERICA: MULTI-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 150
TABLE 134 MIDDLE EAST: MULTI-MODE READERS MARKET, BY REGION 2022–2029 (USD MILLION) 150
TABLE 135 GCC COUNTRIES: MULTI-MODE READERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 150
TABLE 136 CELL COUNTING FLOW CYTOMETERS MARKET, BY REGION 2022–2029 (USD MILLION) 151
TABLE 137 NORTH AMERICA: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 138 EUROPE: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 152
TABLE 139 ASIA PACIFIC: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 152
TABLE 140 LATIN AMERICA: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 141 MIDDLE EAST: CELL COUNTING FLOW CYTOMETERS MARKET, BY REGION 2022–2029 (USD MILLION) 153
TABLE 142 GCC COUNTRIES: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 143 CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE 2022–2029 (USD MILLION) 154
TABLE 144 CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY REGION 2022–2029 (USD MILLION) 154
TABLE 145 NORTH AMERICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 146 EUROPE: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 147 ASIA PACIFIC: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 148 LATIN AMERICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 149 MIDDLE EAST: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 156
TABLE 150 GCC COUNTRIES: CELL COUNTING HEMATOLOGY ANALYZERS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 151 FULLY AUTOMATED ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 157
TABLE 152 NORTH AMERICA: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 157
TABLE 153 EUROPE: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 158
TABLE 154 ASIA PACIFIC: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 158
TABLE 155 LATIN AMERICA: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 158
TABLE 156 MIDDLE EAST: FULLY AUTOMATED ANALYZERS MARKET, BY REGION 2022–2029 (USD MILLION) 159
TABLE 157 GCC COUNTRIES: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 159
TABLE 158 SEMI-AUTOMATED ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 160
TABLE 159 NORTH AMERICA: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 160
TABLE 160 EUROPE: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 160
TABLE 161 ASIA PACIFIC: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 161
TABLE 162 LATIN AMERICA: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 161
TABLE 163 MIDDLE EAST: SEMI-AUTOMATED ANALYZERS MARKET, BY REGION 2022–2029 (USD MILLION) 161
TABLE 164 GCC COUNTRIES: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 162
TABLE 165 CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 166 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 163
TABLE 167 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 168 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 169 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 164
TABLE 170 MIDDLE EAST: CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 164
TABLE 171 GCC COUNTRIES: CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 164
TABLE 172 CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 165
TABLE 173 AUTOMATED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 165
TABLE 174 NORTH AMERICA: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 166
TABLE 175 EUROPE: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 166
TABLE 176 ASIA PACIFIC: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 166
TABLE 177 LATIN AMERICA: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 167
TABLE 178 MIDDLE EAST: AUTOMATED CELL COUNTERS MARKET, BY REGION 2022–2029 (USD MILLION) 167
TABLE 179 GCC COUNTRIES: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 167
TABLE 180 MANUAL CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 168
TABLE 181 NORTH AMERICA: MANUAL CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 168
TABLE 182 EUROPE: MANUAL CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 169
TABLE 183 ASIA PACIFIC: MANUAL CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 169
TABLE 184 LATIN AMERICA: MANUAL CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 169
TABLE 185 MIDDLE EAST: MANUAL CELL COUNTERS MARKET, BY REGION 2022–2029 (USD MILLION) 170
TABLE 186 GCC COUNTRIES: MANUAL CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 170
TABLE 187 CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 171
TABLE 188 FLUORESCENCE-BASED CELL COUNTERS MARKET, BY REGION 2022–2029 (USD MILLION) 172
TABLE 189 NORTH AMERICA: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 190 EUROPE: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 172
TABLE 191 ASIA PACIFIC: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 192 LATIN AMERICA: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 193 MIDDLE EAST: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 194 GCC COUNTRIES: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 195 IMAGE-BASED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 174
TABLE 196 NORTH AMERICA: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 175
TABLE 197 EUROPE: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 175
TABLE 198 ASIA PACIFIC: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 175
TABLE 199 LATIN AMERICA: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 176
TABLE 200 MIDDLE EAST: IMAGE-BASED CELL COUNTERS MARKET, BY REGION 2022–2029 (USD MILLION) 176
TABLE 201 GCC COUNTRIES: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 176
TABLE 202 BRIGHTFIELD CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 177
TABLE 203 NORTH AMERICA: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 177
TABLE 204 EUROPE: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 178
TABLE 205 ASIA PACIFIC: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 178
TABLE 206 LATIN AMERICA: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 178
TABLE 207 MIDDLE EAST: BRIGHTFIELD CELL COUNTERS MARKET, BY REGION 2022–2029 (USD MILLION) 179
TABLE 208 GCC COUNTRIES: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 179
TABLE 209 OTHER CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 180
TABLE 210 NORTH AMERICA: OTHER CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 180
TABLE 211 EUROPE: OTHER CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 180
TABLE 212 ASIA PACIFIC: OTHER CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 181
TABLE 213 LATIN AMERICA: OTHER CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 181
TABLE 214 MIDDLE EAST: OTHER CELL COUNTERS MARKET, BY REGION 2022–2029 (USD MILLION) 181
TABLE 215 GCC COUNTRIES: OTHER CELL COUNTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 182
TABLE 216 CELL COUNTING MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION) 182
TABLE 217 NORTH AMERICA: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 183
TABLE 218 EUROPE: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 183
TABLE 219 ASIA PACIFIC: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 183
TABLE 220 LATIN AMERICA: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 184
TABLE 221 MIDDLE EAST: CELL COUNTING MICROSCOPES MARKET, BY REGION 2022–2029 (USD MILLION) 184
TABLE 222 GCC COUNTRIES: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 184
TABLE 223 OTHER INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 185
TABLE 224 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 185
TABLE 225 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 186
TABLE 226 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 186
TABLE 227 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 186
TABLE 228 MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION 2022–2029 (USD MILLION) 187
TABLE 229 GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 187
TABLE 230 CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 189
TABLE 231 CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE 2022–2029 (USD MILLION) 190
TABLE 232 CELL COUNTING RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 190
TABLE 233 NORTH AMERICA: CELL COUNTING RESEARCH APPLICATIONS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 234 EUROPE: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 235 ASIA PACIFIC: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 236 LATIN AMERICA: CELL COUNTING RESEARCH APPLICATIONS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 237 MIDDLE EAST: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 192
TABLE 238 GCC COUNTRIES: CELL COUNTING RESEARCH APPLICATIONS MARKET BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 239 CANCER RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 194
TABLE 240 NORTH AMERICA: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 241 EUROPE: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 195
TABLE 242 ASIA PACIFIC: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 195
TABLE 243 LATIN AMERICA: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 196
TABLE 244 MIDDLE EAST: CANCER RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 196
TABLE 245 GCC COUNTRIES: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 246 IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 197
TABLE 247 NORTH AMERICA: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 248 EUROPE: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 198
TABLE 249 ASIA PACIFIC: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 250 LATIN AMERICA: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 251 MIDDLE EAST: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 199
TABLE 252 GCC COUNTRIES: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 253 NEUROLOGY RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 200
TABLE 254 NORTH AMERICA: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 255 EUROPE: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 200
TABLE 256 ASIA PACIFIC: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 257 LATIN AMERICA: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 258 MIDDLE EAST: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 201
TABLE 259 GCC COUNTRIES: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 260 STEM CELL RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 203
TABLE 261 NORTH AMERICA: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 203
TABLE 262 EUROPE: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 203
TABLE 263 ASIA PACIFIC: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 264 LATIN AMERICA: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 265 MIDDLE EAST: STEM CELL RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 204
TABLE 266 GCC COUNTRIES: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 267 OTHER RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 205
TABLE 268 NORTH AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 269 EUROPE: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 206
TABLE 270 ASIA PACIFIC: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 206
TABLE 271 LATIN AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 207
TABLE 272 MIDDLE EAST: OTHER RESEARCH APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 207
TABLE 273 GCC COUNTRIES: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 207
TABLE 274 CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE 2022–2029 (USD MILLION) 208
TABLE 275 CELL COUNTING MEDICAL APPLICATIONS MARKET, BY REGION 2022–2029 (USD MILLION) 209
TABLE 276 NORTH AMERICA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 277 EUROPE: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 209
TABLE 278 ASIA PACIFIC: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 279 LATIN AMERICA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 280 MIDDLE EAST: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 210
TABLE 281 GCC COUNTRIES: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 282 HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY REGION 2022–2029 (USD MILLION) 212
TABLE 283 NORTH AMERICA: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 284 EUROPE: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 285 ASIA PACIFIC: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 286 LATIN AMERICA: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 287 MIDDLE EAST: HE